Last edition
News about "USA FDA Hemophilia A or B and Inhibitors"
FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors
The U.S. Food and Drug Administration today approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors (neutralizing antibodies)
USA FDA Hemophilia A Or B And Inhibitors | 02/04/2020 | By Darshana | 371
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members